RVO WEBINARS - GLOBAL

Retinal diseases are a common cause of vision loss worldwide. Among these, retinal vein occlusion (RVO) is a significant concern, being the second most common retinal vascular disease behind diabetic retinopathy.

The Angiogenesis Foundation’s Center of Excellence for Retinal Disorders has created a multimedia toolkit to provide clinicians with information about RVO and its role in vascular instability.

This webinar aimed to redefine the disease state of RVO and discuss the clinical trials and implications of the novel treatments Faricimab, a molecule targeting dual signaling pathways via inhibition of Angiopoietin-2 (Ang-2) and Vascular endothelial growth factor (VEGF-A) to improve vascular stability for durable efficacy.

WEBINAR CONTENT

1. Moderator’s Opening
Dr. William Li

2. Multi-factorial Mechanisms of RVO: the Role of Ang-2 and Vascular Stabilization
Dr. David Wong

3. Targeting Dual Pathways in Retinal Vein Occlusions
Dr. Rishi Singh

4. Efficacy, Safety, and Durability of Faricimab in Macular Edema due to RVO: Results from the Phase 3 BALATON and COMINO Trials Dr. Christiana Dinah

5. Panel Discussion

Panelists: Dr. Andrew Chang, Dr. Junyeop Lee, Dr. Lihteh Wu

Moderator: Dr. Rishi Singh

MODERATOR’S OPENING

Dr. William Li is the CEO and co-founder of the Angiogenesis Foundation where he leads national and international efforts to develop new therapeutic strategies for disease involving the microvasculature, including retinopathy. Dr. Li has authored more than 100 publications including a New York Times Bestseller.

Dr. William Li, MD
The Angiogenesis Foundation

PRESENTATION 1

Dr. David Wong, MD, FRCSC, FASRS, DRCPSC

Ophthalmologist-in-chief, Unity Health, Toronto St. Michael's Hospital, University of Toronto

PRESENTATION 2

Dr. Rishi Singh, MD

Chief Medical Officer, Cleveland Clinic Martin North and Cleveland Clinic South Hospitals, Professor of Ophthalmology, Cleveland Clinic's Lerner College of Medicine

PRESENTATION 3

Dr. Christiana Dinah, BSc. MB BS, MRes

Consultant Ophthalmologist and Medical Retina Specialist, London Northwest University Healthcare NHS Trust

PANEL DISCUSSION

PANELISTS

  • Dr. Andrew Chang, AMMBBS (Hons), PhD (USYD), FRANZCO FRACS

    Associate Professor, University of Sydney, Consultant Ophthalmologist, Sydney Eye Hospital

  • Dr. Junyeop Lee, MD

    Vitreoretinal Surgeon and Associate Professor, Asan Medical Center, University of Ulsan College of Medicine

  • Dr. Lihteh Wu, MD

    Associate Professor of Ophthalmology, University of Costa Rica